Press releases
- LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
- LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
- LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
- LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
- LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
More ▼
Key statistics
On Tuesday, LivaNova PLC (L2IV34:SAO) closed at 41.65, 0.00% below its 52-week high of 41.65, set on Jul 26, 2022.
52-week range
Markit short selling activity
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 41.65 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 26 2022.
More ▼